Year: 2022 | Month: June | Volume 9 | Issue 1
Pulmonary Complications among Discharged COVID-19 Patients – A Prospective Study
Suhail Neliyathodi
Akshaya Kumar
DOI:10.30954/IJDMS.1.2022.3
Abstract:
Background: There is a need for a unified pathway and structure for the respiratory follow-up of patients with COVID-19 pneumonia. Introduction: The long-term complications of COVID-19 pneumonia-pulmonary fibrosis, pulmonary vascular disease, bronchial hyper-reactivity, and pleural effusion are real and need evaluation. Methodology: A prospective study was conducted in November 2020–January 2021 among the patients discharged from MES COVID hospital. Aim: The aims of this study were to estimate the prevalence of pulmonary complications among discharged COVID-19 patients and to study the risk factors and long-term outcome of pulmonary fibrosis in COVID. Results: Out of the 300 patients studied, most common outcome was pulmonary fibrosis – 10.7%; followed by death (9%), pleural effusion (2%), bronchial hyper-reactivity (1.3%), pulmonary embolism (0.3%), anosmia (0.3%), pneumothorax (0.3%), and organizing pneumonia (0.3%). Conclusion: Most of the complications were seen among Cat-C patients, the most common being pulmonary fibrosis which showed a serial decrement in the chest X-ray scores suggesting favorable outcome.
Print This Article Email This Article to Your Friend
